Jenna Davidner
Stock Analyst at Barclays
(0.84)
# 3,844
Out of 4,421 analysts
20
Total ratings
28.6%
Success rate
-6.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $18 | $10.88 | +65.44% | 3 | May 15, 2026 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $100 | $63.16 | +58.33% | 5 | May 15, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $25 | $22.33 | +11.96% | 4 | May 14, 2026 | |
| XERS Xeris Biopharma Holdings | Rated: Buy | $9 | $6.95 | +29.50% | 3 | May 13, 2026 | |
| COLL Collegium Pharmaceutical | Rated: Buy | $56 | $33.54 | +66.96% | 5 | May 12, 2026 |
Phathom Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $10.88
Upside: +65.44%
Tarsus Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100
Current: $63.16
Upside: +58.33%
Pacira BioSciences
May 14, 2026
Maintained: Hold
Price Target: $25
Current: $22.33
Upside: +11.96%
Xeris Biopharma Holdings
May 13, 2026
Rated: Buy
Price Target: $9
Current: $6.95
Upside: +29.50%
Collegium Pharmaceutical
May 12, 2026
Rated: Buy
Price Target: $56
Current: $33.54
Upside: +66.96%